Literature DB >> 25732745

Epidemiology and risk factors for IBD.

Ashwin N Ananthakrishnan1.   

Abstract

IBD, comprising Crohn's disease and ulcerative colitis, is a chronic immunologically mediated disease at the intersection of complex interactions between genetics, environment and gut microbiota. Established high-prevalence populations of IBD in North America and Europe experienced the steepest increase in incidence towards the second half of the twentieth century. Furthermore, populations previously considered 'low risk' (such as in Japan and India) are witnessing an increase in incidence. Potentially relevant environmental influences span the spectrum of life from mode of childbirth and early-life exposures (including breastfeeding and antibiotic exposure in infancy) to exposures later on in adulthood (including smoking, major life stressors, diet and lifestyle). Data support an association between smoking and Crohn's disease whereas smoking cessation, but not current smoking, is associated with an increased risk of ulcerative colitis. Dietary fibre (particularly fruits and vegetables), saturated fats, depression and impaired sleep, and low vitamin D levels have all been associated with incident IBD. Interventional studies assessing the effects of modifying these risk factors on natural history and patient outcomes are an important unmet need. In this Review, the changing epidemiology of IBD, mechanisms behind various environmental associations and interventional studies to modify risk factors and disease course are discussed.

Entities:  

Mesh:

Year:  2015        PMID: 25732745     DOI: 10.1038/nrgastro.2015.34

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  202 in total

1.  Active and passive smoking in childhood is related to the development of inflammatory bowel disease.

Authors:  Suhal S Mahid; Kyle S Minor; Arnold J Stromberg; Susan Galandiuk
Journal:  Inflamm Bowel Dis       Date:  2007-04       Impact factor: 5.325

2.  Non-smoking: a feature of ulcerative colitis.

Authors:  A D Harries; A Baird; J Rhodes
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-06

3.  Occupational distribution of inflammatory bowel disease among German employees.

Authors:  A Sonnenberg
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

4.  An association between dietary arachidonic acid, measured in adipose tissue, and ulcerative colitis.

Authors:  Punyanganie S A de Silva; Anja Olsen; Jane Christensen; Erik Berg Schmidt; Kim Overvaad; Anne Tjonneland; Andrew R Hart
Journal:  Gastroenterology       Date:  2010-10-13       Impact factor: 22.682

5.  Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors.

Authors:  J R Goodhand; M Wahed; J E Mawdsley; A D Farmer; Q Aziz; D S Rampton
Journal:  Inflamm Bowel Dis       Date:  2012-02-22       Impact factor: 5.325

Review 6.  Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis.

Authors:  Martin Feller; Karin Huwiler; Roger Stephan; Ekkehardt Altpeter; Aijing Shang; Hansjakob Furrer; Gaby E Pfyffer; Thomas Jemmi; Andreas Baumgartner; Matthias Egger
Journal:  Lancet Infect Dis       Date:  2007-09       Impact factor: 25.071

7.  Diet in the aetiology of ulcerative colitis: a European prospective cohort study.

Authors:  Andrew R Hart; Robert Luben; Anja Olsen; Anne Tjonneland; Jakob Linseisen; Gabriele Nagel; Goran Berglund; Stefan Lindgren; Olof Grip; Timothy Key; Paul Appleby; Manuela M Bergmann; Heiner Boeing; Goran Hallmans; Ake Danielsson; Richard Palmqvist; Hubert Sjodin; Gun Hagglund; Kim Overvad; Domenico Palli; Giovanna Masala; Elio Riboli; Hugh Kennedy; Ailsa Welch; Kay-Tee Khaw; Nicholas Day; Sheila Bingham
Journal:  Digestion       Date:  2008-03-18       Impact factor: 3.216

8.  Infectious gastroenteritis and risk of developing inflammatory bowel disease.

Authors:  Chad K Porter; David R Tribble; Pablo A Aliaga; Heather A Halvorson; Mark S Riddle
Journal:  Gastroenterology       Date:  2008-06-05       Impact factor: 22.682

Review 9.  Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis.

Authors:  D Turner; A H Steinhart; A M Griffiths
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

10.  Linking long-term dietary patterns with gut microbial enterotypes.

Authors:  Gary D Wu; Jun Chen; Christian Hoffmann; Kyle Bittinger; Ying-Yu Chen; Sue A Keilbaugh; Meenakshi Bewtra; Dan Knights; William A Walters; Rob Knight; Rohini Sinha; Erin Gilroy; Kernika Gupta; Robert Baldassano; Lisa Nessel; Hongzhe Li; Frederic D Bushman; James D Lewis
Journal:  Science       Date:  2011-09-01       Impact factor: 47.728

View more
  433 in total

Review 1.  The global burden of IBD: from 2015 to 2025.

Authors:  Gilaad G Kaplan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

Review 2.  Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD.

Authors:  Matthew R Kudelka; Sean R Stowell; Richard D Cummings; Andrew S Neish
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-07-24       Impact factor: 46.802

Review 3.  Pathway-based approaches to the treatment of inflammatory bowel disease.

Authors:  Giorgos Bamias; Theresa T Pizarro; Fabio Cominelli
Journal:  Transl Res       Date:  2015-09-07       Impact factor: 7.012

4.  Therapeutic Effects of Mesenchymal Stem Cells Derived From Bone Marrow, Umbilical Cord Blood, and Pluripotent Stem Cells in a Mouse Model of Chemically Induced Inflammatory Bowel Disease.

Authors:  Argyro Kagia; Maria Tzetis; Emmanuel Kanavakis; Despina Perrea; Irene Sfougataki; Anny Mertzanian; Ioanna Varela; Aikaterini Dimopoulou; Angeliki Karagiannidou; Evgenios Goussetis
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

Review 5.  Association Between Adipokines Levels with Inflammatory Bowel Disease (IBD): Systematic Reviews.

Authors:  Nava Morshedzadeh; Mehran Rahimlou; Hamid Asadzadeh Aghdaei; Shabnam Shahrokh; Mohammad Reza Zali; Parvin Mirmiran
Journal:  Dig Dis Sci       Date:  2017-10-30       Impact factor: 3.199

6.  Fecal Microbiota Transplant via Endoscopic Delivering Through Small Intestine and Colon: No Difference for Crohn's Disease.

Authors:  Zhenyu Yang; Chibin Bu; Wei Yuan; Zhaohua Shen; Yongsheng Quan; Shuai Wu; Changxin Zhu; Xiaoyan Wang
Journal:  Dig Dis Sci       Date:  2019-07-31       Impact factor: 3.199

Review 7.  A product review of vedolizumab in inflammatory bowel disease.

Authors:  Robert Battat; Parambir S Dulai; Vipul Jairath; Niels Vande Casteele
Journal:  Hum Vaccin Immunother       Date:  2019-05-07       Impact factor: 3.452

8.  Association of Smoking and Obesity on the Risk of Developing Primary Sjögren Syndrome: A Population-based Cohort Study.

Authors:  Luisa Servioli; Gabriel Maciel; Carlotta Nannini; Cynthia S Crowson; Eric L Matteson; Divi Cornec; Alvise Berti
Journal:  J Rheumatol       Date:  2019-01-15       Impact factor: 4.666

9.  Diet Modifies Colonic Microbiota and CD4+ T-Cell Repertoire to Induce Flares of Colitis in Mice With Myeloid-Cell Expression of Interleukin 23.

Authors:  Lili Chen; Zhengxiang He; Alina Cornelia Iuga; Sebastião N Martins Filho; Jeremiah J Faith; Jose C Clemente; Madhura Deshpande; Anitha Jayaprakash; Jean-Frederic Colombel; Juan J Lafaille; Ravi Sachidanandam; Glaucia C Furtado; Sergio A Lira
Journal:  Gastroenterology       Date:  2018-06-15       Impact factor: 22.682

10.  Endogenous Specialized Proresolving Mediator Profiles in a Novel Experimental Model of Lymphatic Obstruction and Intestinal Inflammation in African Green Monkeys.

Authors:  Felix Becker; Emily Romero; Jason Goetzmann; Dana L Hasselschwert; Beth Dray; John Vanchiere; Jane Fontenot; J Winny Yun; Paul C Norris; Luke White; Melany Musso; Charles N Serhan; J Steven Alexander; Felicity N E Gavins
Journal:  Am J Pathol       Date:  2019-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.